Written Question·Department of Health and Social Care·UIN 119737

Neurological Diseases: Drugs

Tabled: 10 March 2026

Answered: 17 March 2026

Named Day

Question

Freddie van Mierlo

To ask the Secretary of State for Health and Social Care, what assessment he has made of the effectiveness of the Early Access to Medicines Scheme in facilitating patient access to new treatments for neuromuscular diseases.

Answer

Dr Zubir Ahmed

The Medicines and Healthcare products Regulatory Agency (MHRA) supports access to treatments for people living with neuromuscular diseases. The majority of neuromuscular diseases are defined as rare diseases. On the 2 November 2025, the MHRA published a p...

ⓘ

This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 119737) →